This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Petri M (2000) Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 9: 170–175
Grootscholten C and Berden JH (2006) Discontinuation of immunosuppression in proliferative lupus nephritis: is it possible? Nephrol Dial Transplant 21: 1465–1469
Mosca M et al. (2002) Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis. Kidney Int 61: 1502–1509
Mosca M et al. (2001) Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis. Lupus 10: 253–257
Mok CC et al. (2006) Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med 119: e25–e33
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Szeto, CC., Tam, LS. Maintenance treatment of proliferative lupus nephritis can be discontinued after remission in some patients. Nat Rev Nephrol 2, 672–673 (2006). https://doi.org/10.1038/ncpneph0333
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0333
This article is cited by
-
Treatment of proliferative lupus nephritis: a slowly changing landscape
Nature Reviews Nephrology (2011)